In the data obtained from the cohort, proteins such as TTR, SRSF10, RPS21, SRP9, DBI, BTF3, GZMK, RO60, STMN1, ENAM and CD59 had significant prognostic value in both the T1DM and MS groups. This evidence concerns the gene STMN1 and myeloid sarcoma.